Artesunate for Severe Acute Plasmodium falciparum Infection in a Patient with Myasthenia Gravis

We report a case of severe malaria in a patient with underlying myasthenia gravis who was successfully treated with artesunate. The outcome was favorable. Artesunate seems to be a good option for patients with underlying myasthenia gravis disease because they benefit from a better toxicity profile than quinine.